141 related articles for article (PubMed ID: 35947885)
1. Effectiveness of clinical and instrumental follow-up for cutaneous melanoma.
Toia F; Cajozzo M; Rosatti F; Di Lorenzo S; Rinaldi G; Mazzucco W; Cordova A
Surg Oncol; 2022 Sep; 44():101821. PubMed ID: 35947885
[TBL] [Abstract][Full Text] [Related]
2. Surveillance strategies in the follow-up of melanoma patients: too much or not enough?
Kurtz J; Beasley GM; Agnese D; Kendra K; Olencki TE; Terando A; Howard JH
J Surg Res; 2017 Jun; 214():32-37. PubMed ID: 28624057
[TBL] [Abstract][Full Text] [Related]
3. Stage-Based Detection Methods and Recurrence Patterns for Cutaneous Melanoma.
Sullivan FG; Adler KB; Boudreaux MD; Hensley LM; Roberts ME; Liles JS; Howard JH
Am Surg; 2024 Jul; 90(7):1963-1965. PubMed ID: 38549200
[TBL] [Abstract][Full Text] [Related]
4. Method of detection of initial recurrence of stage II/III cutaneous melanoma: analysis of the utility of follow-up staging.
Meyers MO; Yeh JJ; Frank J; Long P; Deal AM; Amos KD; Ollila DW
Ann Surg Oncol; 2009 Apr; 16(4):941-7. PubMed ID: 19101766
[TBL] [Abstract][Full Text] [Related]
5. Is surveillance imaging effective for detecting surgically treatable recurrences in patients with melanoma? A comparative analysis of stage-specific surveillance strategies.
Rueth NM; Xing Y; Chiang YJ; Cromwell KD; Ross MI; Lee JE; Gershenwald JE; Royal RE; Cormier JN
Ann Surg; 2014 Jun; 259(6):1215-22. PubMed ID: 24096759
[TBL] [Abstract][Full Text] [Related]
6. Routine restaging PET/CT and detection of initial recurrence in sentinel lymph node positive stage III melanoma.
Baker JJ; Meyers MO; Frank J; Amos KD; Stitzenberg KB; Ollila DW
Am J Surg; 2014 Apr; 207(4):549-54. PubMed ID: 24674829
[TBL] [Abstract][Full Text] [Related]
7. Optimal surveillance strategies for patients with stage 1 cutaneous melanoma post primary tumour excision: three systematic reviews and an economic model.
Vale L; Kunonga P; Coughlan D; Kontogiannis V; Astin M; Beyer F; Richmond C; Wilson D; Bajwa D; Javanbakht M; Bryant A; Akor W; Craig D; Lovat P; Labus M; Nasr B; Cunliffe T; Hinde H; Shawgi M; Saleh D; Royle P; Steward P; Lucas R; Ellis R
Health Technol Assess; 2021 Nov; 25(64):1-178. PubMed ID: 34792018
[TBL] [Abstract][Full Text] [Related]
8. A rational approach to the follow-up of melanoma patients.
Garbe C
Recent Results Cancer Res; 2002; 160():205-15. PubMed ID: 12079215
[TBL] [Abstract][Full Text] [Related]
9. Follow-up recommendations for patients with American Joint Committee on Cancer Stages I-III malignant melanoma.
Poo-Hwu WJ; Ariyan S; Lamb L; Papac R; Zelterman D; Hu GL; Brown J; Fischer D; Bolognia J; Buzaid AC
Cancer; 1999 Dec; 86(11):2252-8. PubMed ID: 10590365
[TBL] [Abstract][Full Text] [Related]
10. Follow-up recommendations for patients with stage I malignant melanoma.
Romero JB; Stefanato CM; Kopf AW; Bart RS
J Dermatol Surg Oncol; 1994 Mar; 20(3):175-8. PubMed ID: 8151030
[TBL] [Abstract][Full Text] [Related]
11. [Follow-up for cutaneous melanoma].
Kettelhack C
Ther Umsch; 2008 Jun; 65(6):335-40. PubMed ID: 18622957
[TBL] [Abstract][Full Text] [Related]
12. Is ultrasound lymph node examination superior to clinical examination in melanoma follow-up? A monocentre cohort study of 373 patients.
Machet L; Nemeth-Normand F; Giraudeau B; Perrinaud A; Tiguemounine J; Ayoub J; Alison D; Vaillant L; Lorette G
Br J Dermatol; 2005 Jan; 152(1):66-70. PubMed ID: 15656802
[TBL] [Abstract][Full Text] [Related]
13. Surveillance and follow-up examinations in cutaneous melanoma.
Garbe C; Schadendorf D
Onkologie; 2003 Jun; 26(3):241-6. PubMed ID: 12845208
[TBL] [Abstract][Full Text] [Related]
14. Pattern and incidence of first site recurrences following sentinel node procedure in melanoma patients.
Statius Muller MG; van Leeuwen PA; van Diest PJ; Pijpers R; Nijveldt RJ; Vuylsteke RJ; Meijer S
World J Surg; 2002 Dec; 26(12):1405-11. PubMed ID: 12297910
[TBL] [Abstract][Full Text] [Related]
15. Methods of detection of first recurrence in patients with stage I/II primary cutaneous melanoma after sentinel lymph node biopsy.
Moore Dalal K; Zhou Q; Panageas KS; Brady MS; Jaques DP; Coit DG
Ann Surg Oncol; 2008 Aug; 15(8):2206-14. PubMed ID: 18512102
[TBL] [Abstract][Full Text] [Related]
16. Optimizing the frequency of follow-up visits for patients treated for localized primary cutaneous melanoma.
Turner RM; Bell KJ; Morton RL; Hayen A; Francken AB; Howard K; Armstrong B; Thompson JF; Irwig L
J Clin Oncol; 2011 Dec; 29(35):4641-6. PubMed ID: 22067399
[TBL] [Abstract][Full Text] [Related]
17. Clinicopathologic features correlated with paradoxical outcomes in stage IIC versus IIIA melanoma patients.
Tan SY; Najita J; Li X; Strazzulla LC; Dunbar H; Lee MY; Seery VJ; Buchbinder EI; Tawa NE; McDermott DF; Lee SJ; Atkins MB; Kim CC
Melanoma Res; 2019 Feb; 29(1):70-76. PubMed ID: 30169431
[TBL] [Abstract][Full Text] [Related]
18. Vulvar melanoma: is there a role for sentinel lymph node biopsy?
de Hullu JA; Hollema H; Hoekstra HJ; Piers DA; Mourits MJ; Aalders JG; van der Zee AG
Cancer; 2002 Jan; 94(2):486-91. PubMed ID: 11905414
[TBL] [Abstract][Full Text] [Related]
19. Male sex and Breslow thickness are important risk factors for recurrence of localized melanoma in Korean populations.
Oh Y; Choi S; Cho MY; Nam KA; Shin SJ; Chang JS; Oh BH; Roh MR; Chung KY
J Am Acad Dermatol; 2020 Oct; 83(4):1071-1079. PubMed ID: 31562946
[TBL] [Abstract][Full Text] [Related]
20. Cost-effectiveness analysis of imaging strategy for an intensive follow-up of patients with American Joint Committee on Cancer stage IIB, IIC and III malignant melanoma.
Podlipnik S; Moreno-Ramírez D; Carrera C; Barreiro A; Manubens E; Ferrandiz-Pulido L; Sánchez M; Vidal-Sicart S; Malvehy J; Puig S
Br J Dermatol; 2019 May; 180(5):1190-1197. PubMed ID: 29876940
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
